FPAS
BIIB icon

Focus Partners Advisor Solutions’s Biogen BIIB Stock Holding History

Focus Partners Advisor Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Sell
7,689
-1,322
-15% -$253K 0.01% 407
2026
Q1 		$1.65M Buy
9,011
+1,506
+20% +$277K 0.02% 403
2025
Q4 		$1.32M Buy
7,505
+118
+2% +$19.3K 0.02% 418
2025
Q3 		$1.13M Buy
7,387
+1,076
+17% +$145K 0.01% 482
2025
Q2 		$793K Buy
6,311
+1,010
+19% +$126K 0.01% 511
2025
Q1 		$725K Buy
+5,301
New +$758K 0.01% 469
2024
Q4 		– Sell
-1,655
Closed -$321K – 780
2024
Q3 		$321K Buy
1,655
+539
+48% +$113K 0.01% 550
2024
Q2 		$259K Buy
1,116
+152
+16% +$33K 0.01% 525
2024
Q1 		$208K Buy
+964
New +$226K 0.01% 574
2023
Q1 		– Sell
-757
Closed -$210K – 360
2022
Q4 		$210K Sell
757
-919
-55% -$260K 0.02% 318
2022
Q3 		$448K Buy
+1,676
New +$356K 0.03% 240

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focus Partners Advisor Solutions's BIIB Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Biogen (BIIB) stake by 15% in Q2 2026, selling an estimated $253K and leaving 7,689 shares worth $1.66M. The position accounts for 0.01% of the portfolio, ranked #407.

Focus Partners Advisor Solutions first reported a position in BIIB in Q3 2022 and has held it in 11 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Focus Partners Advisor Solutions held 7,689 shares of Biogen worth $1.66M as of Q2 2026.
  • Focus Partners Advisor Solutions sold 1,322 Biogen shares in Q2 2026, an estimated $253K.
  • Biogen made up 0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #407 holding.
  • Focus Partners Advisor Solutions first reported a position in Biogen in Q3 2022 and has held it in 11 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.